Page last updated: 2024-09-03

1'-acetoxychavicol acetate and Body Weight

1'-acetoxychavicol acetate has been researched along with Body Weight in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdalla, YOA; Arshad, NM; Awang, K; Mun, KS; Nagoor, NH; Nyamathulla, S; Shamsuddin, N1
Hara, A; Kawabata, K; Kawamori, T; Koshimizu, K; Makita, H; Mori, H; Murakami, A; Ohigashi, H; Satoh, K; Tanaka, T1

Other Studies

2 other study(ies) available for 1'-acetoxychavicol acetate and Body Weight

ArticleYear
Acute and 28-day sub-acute intravenous toxicity studies of 1'-S-1'-acetoxychavicol acetate in rats.
    Toxicology and applied pharmacology, 2018, 10-01, Volume: 356

    Topics: Administration, Intravenous; Animals; Antineoplastic Agents, Phytogenic; Behavior, Animal; Benzyl Alcohols; Blood Cell Count; Body Weight; Drinking; Eating; Female; Inflammation; Lethal Dose 50; Male; No-Observed-Adverse-Effect Level; Rats; Rats, Sprague-Dawley; Toxicity Tests, Subchronic

2018
A xanthine oxidase inhibitor 1'-acetoxychavicol acetate inhibits azoxymethane-induced colonic aberrant crypt foci in rats.
    Carcinogenesis, 1997, Volume: 18, Issue:5

    Topics: Animals; Antineoplastic Agents; Azoxymethane; Benzyl Alcohols; Body Weight; Cell Division; Colon; Colonic Diseases; Enzyme Inhibitors; Intestinal Mucosa; Liver; Male; Organ Size; Ornithine Decarboxylase; Polyamines; Precancerous Conditions; Rats; Rats, Inbred F344; Terpenes; Xanthine Oxidase

1997